PTYLTD
    • Free Reports
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Free Reports

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks

Insights into ASX Stocks

HUB24 (ASX: HUB)

HUB24 (ASX: HUB): Platform Leadership and Scalable Profitability

Jul 10, 2026
Proactive Equities Team

HUB24 Limited (ASX: HUB) delivers record inflows, expanding margins, and disciplined execution, reinforcing its leadership in wealth‑tech platforms and positioning for sustained shareholder value through scalable growth

Northern Minerals (ASX: NTU)

Northern Minerals (ASX: NTU): Rare-Earth Momentum Builds as NTU Tests a Make-or-Break Support Zone

Jul 10, 2026
Proactive Equities Team

Northern Minerals remains focused on advancing its Browns Range rare earths project while progressing FEED work and expanding resources at Dazzler. The stock is consolidating near key support as investors monitor funding, governance changes, and project milestones

ANZ Group Holdings (ASX: ANZ)

ANZ Group Holdings (ASX: ANZ): Repricing Discipline and Transformation Momentum

Jul 9, 2026
Proactive Equities Team

ANZ Group Holdings (ASX: ANZ) delivers resilient profitability, disciplined cost control, and strong capital ratios, positioning for sustained shareholder returns amid strategic transformation and integration momentum

Minerals 260 (ASX: MI6)

Minerals 260 (ASX: MI6) Breaches Key Support: Is the Bull Run Over?

Jul 9, 2026
Proactive Equities Team

Minerals 260 has boosted Bullabulling to a 6.2Moz gold resource and unveiled a maiden reserve and PFS supporting a 19-year mine. Despite strong fundamentals, MI6 has slipped below trendline support, prompting investors to watch key technical levels closely

Sigma Healthcare (ASX: SIG)

Sigma Healthcare (ASX: SIG): Integrated Scale, Relentless Momentum

Jul 8, 2026
Proactive Equities Team

Sigma Healthcare (ASX: SIG) delivers strong double‑digit growth and disciplined integration, positioning the merged Chemist Warehouse group for sustained expansion across domestic and international markets

Island Pharmaceuticals (ASX: ILA)

Island Pharmaceuticals (ASX: ILA) Breaks Its Downtrend as Galidesivir News Puts It Back in Play

Jul 8, 2026
Proactive Equities Team

Island Pharmaceuticals has regained market attention after breaking a long-term downtrend, supported by Galidesivir developments and strong trading momentum. Recent updates across biodefence, manufacturing, and intellectual property have improved sentiment, although confirmation above key resistance remains important

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1...456...43
Page 5 of 43